CRABP1 and vitiligo: It appeared that Crabp1 expression was dramatically and significantly reduced in multiple human inflammatory diseases including multiple sclerosis, lupus, inflammatory bowel diseases, vitiligo and psoriasis [34–38] (Fig. 3d).